期刊文献+

体外评价羧甲基壳聚糖超顺磁氧化铁纳米粒的细胞毒性和巨噬细胞的摄取 被引量:2

The in vitro evaluation on O-carboxymethyl chitosan superparamagnetic iron oxide nanoparticles
原文传递
导出
摘要 目的体外评价自制羧甲基壳聚糖超顺磁氧化铁纳米粒(OCMCS-SPIO-NPs)的细胞毒性和逃避巨噬细胞的吞噬能力。方法以菲立磁和未包被的超顺磁氧化铁纳米粒为对照,采用四唑盐(MTT)比色法考察OCMCS-SPIO-NPs对LO2细胞(正常肝细胞株)和A549(人肺腺癌细胞株)的细胞毒性;用菲洛嗪法及普鲁士蓝法考察OCMCS-SPIO-NPs纳米粒并评价其体外的抗吞噬能力。结果 SPIO-NPs经羧甲基壳聚糖共价修饰后,对LO2和A549细胞的细胞毒性明显降低,OCMCS-SPIO-NPs的细胞毒性和dextran-SPIO的细胞毒性无显著性差异(P>0.05),其细胞毒性与培养基中SPIO的浓度呈正相关;与3种SPIO纳米粒孵化24h后,RAW264.7细胞内铁含量随培养基中SPIO的含量增加而增加,细胞内铁含量依次为:未包被SPIO-NPs>dextran-SPIO-NPs>CMCS-SPIO-NPs组(P<0.05)。结论超顺氧化铁纳米粒经羧甲基壳聚糖共价修饰后能显著降低细胞毒性和吞噬细胞摄取,提高了生物相容性,显著降低了巨噬细胞对其的摄取。 OBJECTIVE To investigate cell cytotoxicity and the ability to evade the capture by macrophage of O-carboxymethyl chitosan superparamagnetic iron oxide nanoparticles by comparing with Ferumoxides(dextran-SPIO-NPs)and uncoated SPIO-NPs.METHODS Tetrazolium salt(MTT) assay was used to evaluate cell cytotoxicity of the three SPIO-NPs against LO2(normal liver cells)and A549(human lung adenocarcinoma cells).After being incubated with dextran-SPIO-NPs,uncoated-SPIO-NPs or OCMCS-SPIO-NPs respectively,the intracellular iron content in mouse macrophage(RAW 264.7)was visualized by Prussian blue staining,and quantified by Ferrozine assay.RESULTS The cytotoxicity of both OCMCS-SPIO-NPs and dextran-SPIO-NPs were significantly lower than that of uncoated-SPIO-NPs(P 0.01),while there was no significant differencce between the cytotoxitcity of OCMCS-SPIO-NPs and dextran-SPIO-NPs(P 0.05),The intracellular iron content results indicated that there was a dose dependent increase in intracellular iron content in RAW264.7 cell.Both the Ferrozine assay and Prussian blue staining showed that there was a significant difference among the three groups in intracellular iron content in RAW264.7 cell incubated with OCMCS SPIO-NPs,dextran-SPIO-NPs or uncoated-SPIO-NPs for 24 h.The result was as follows:Uncoated-SPIO-NPs Ferumoxides OCMCS-SPIO-NPs(P 0.05).CONCLUSION The surface modification with O-carboxymethyl chitosan can sharply reduce the cell cytotoxicity of superparamagnetic iron oxide nanoparticles and macrophages cellular uptake.The OCMCS SPIO-NPs had low cytotoxicity,good biocompatibility and low macrophage cellular uptake.
出处 《华西药学杂志》 CAS CSCD 北大核心 2010年第3期290-293,共4页 West China Journal of Pharmaceutical Sciences
关键词 羧甲基壳聚糖超顺磁氧化铁纳米粒 细胞毒性 巨噬细胞摄取 体外 OCMCS-SPIO-NPs Cytotoxicity Macrophage uptake in vitro
  • 相关文献

参考文献5

  • 1Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications [ J ]. Biomaterials,2005,26 ( 18 ) : 3995 - 4021.
  • 2Gupta AK,Gupta M. Cytotoxieity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles [J].Biomaterials, 2005 ,26 ( 13 ) : 1565 - 1573.
  • 3Muller K, Skepper JN, Posfai M, et al. Effect of ultrasmall superparamagnetic iron oxide nanoparticles ( Ferumoxtran - 10) on human monocyte - macrophages in vitro [ J ]. Biomaterials, 2007, 28(9) :1629 - 1642.
  • 4Corot C, Robert P, Idee JM, et al. Recent advances in iron oxide nanocrystal technology for medical imaging[J].Adv Drug Deliv Rev, 2006,58(14) :1471 - 1504.
  • 5李光存,张忻宇.USPIO增强MRI在诊断颈部转移淋巴结中的应用[J].实用放射学杂志,2007,23(5):697-698. 被引量:3

二级参考文献12

  • 1Anzai Y,Piccoli CW,Outwater EK,et al.Evaluation of neck and body metastases to nodes with Combidex-enhanced MR imaging:phase Ⅲ safety and efficacy study[J].Radiology,2003,228(3):777-788.
  • 2Stets C,Brandt S,Wallis F,et al.Axillary lymph node metastases:a statistical analysis of various parameters in MRI with USPIO[J].JMRI,2002,16(1):60-68.
  • 3Siganal R,Vogl T,Casselman J,et al.Lymph node metastases from head and neck squamous cell carcinoma:MR imaging with uhrasmall superparamagnetie iron oxide(Sinerem MR)-results of a phase Ⅲ muhieenter clinical trial[J].Eur Raiol,2002,12(5):1104-1113.
  • 4Hoffman HT,Quets J,Toshiaki T,et al.Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathy[J].Laryngoscope,2000.110(9):1425-1430.
  • 5Ward J,Guthrie JA,Scott DJ,et al.Hepatocellular carcinoma in the cirrhotic liver:double contrast MR imaging for diagnosis[J].Radiology,2000,216(1):154-162.
  • 6Kim YK,Kim CS,Lee YH,et al.Comparison of superparamagnetie iron oxide-enhanced dynamic MRI for detection of small hcpatocellular carcinomas[J].AJR,2004,182(3):1217-1223.
  • 7Johnson JT.A surgeon looks at cervical lymph nodes[J].Radiology,1990,175(3):607-610.
  • 8Mendenhall WM,Million RR,Assisi JH.Elective neck irradiation in squamous carcinoma of the head neck[J].Head Neck Surg,1980,3(1):15-20.
  • 9Castelijns JA,vanden Brekel MW.Imaging of lymph adenopathy in the neck[J].Eur Radiol,2002,12(4):727-738.
  • 10Harisinghani MG,Saini S,Weissleder R,et al.Differentiation of liver hemangiomas fitm metastases and hepatocelluar carcinoma at MR imaging enhanced with blood pool contrast agent Code-7227[J].Radiology,1997,202(3):687-691.

共引文献2

同被引文献12

  • 1王国斌,夏泽锋,陶凯雄,周立国,刘敬伟,肖勇,李剑星.医用纳米级Fe_3O_4磁流体的急性毒理学实验研究[J].华中科技大学学报(医学版),2004,33(4):452-454. 被引量:14
  • 2Sumio C, Tomoharu T, Toshinobu S,et al. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification[ J]. J Pharmacy and Phar- macology ,2007,59:75 - 80.
  • 3Sumio C, Tomoharu T, Toshiobu S, et al. Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes [ J ]. J Drug Targeting,2006,14 ( 8 ) :557 - 566.
  • 4Panchagnula R, Sood A, Sharda N, et al. Determination of rifampi- cin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method[J]. J Pharmaceuti- cal and Biomedical Analysis, 1999 : 1013 - 1020.
  • 5Corot C, Robert P, Jean-Marc I, et al. Recent advances in iron oxide nanocrystal technology for medical imaging [J]. Advanced Drug Delivery Reviews, 2006, 58 (14) : 1 471.
  • 6Fan C, Gao W, Chen Z, et al. Tumor selectivity of steal- th multi-functionalized superparamagnetic iron oxide na- noparticles[J]. Int JPharm, 2011, 404( 1-2 ) : 180.
  • 7Mansouri S, Cuie Y, Winnik F, et al. Characterization of folate-chitosan-DNA nanoparticles for gene therapy[J]. Biomaterials, 2006, 27(9). 2 060.
  • 8Molday RS, MacKenzie D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic sep- aration of cells[J]. J Immunol Methods, 1982, 52 (3) : 353.
  • 9中华人民共和国卫生部药政局.新药(西药)临床前研究指导原则汇编(药学、药理学、毒理学)[s].1993:199.
  • 10Sun C, Lee JS, Zhang M. Magnetic nanoparticle in MR imaging and drug delivery[J]. Advanced Drug Delivery Reviews, 2008, 60( 11 ) : 1 252.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部